Shares of Crescent Capital BDC, Inc. (NASDAQ:CCAP – Get Free Report) have received a consensus rating of “Moderate Buy” from the four research firms that are covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation, one has issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is $16.3333.
A number of research firms have recently weighed in on CCAP. Zacks Research cut Crescent Capital BDC from a “hold” rating to a “strong sell” rating in a report on Wednesday, October 15th. Wall Street Zen upgraded Crescent Capital BDC from a “sell” rating to a “hold” rating in a research note on Friday, June 27th. LADENBURG THALM/SH SH upgraded Crescent Capital BDC to a “strong-buy” rating in a research note on Friday, August 15th. Finally, Keefe, Bruyette & Woods upgraded Crescent Capital BDC from a “hold” rating to a “moderate buy” rating in a research note on Tuesday, July 22nd.
Check Out Our Latest Stock Report on Crescent Capital BDC
Insider Buying and Selling
Institutional Investors Weigh In On Crescent Capital BDC
Institutional investors have recently added to or reduced their stakes in the company. Catalyst Capital Advisors LLC purchased a new stake in Crescent Capital BDC during the second quarter valued at about $69,000. XTX Topco Ltd purchased a new stake in Crescent Capital BDC during the second quarter valued at about $165,000. Catalina Capital Group LLC purchased a new stake in Crescent Capital BDC during the second quarter valued at about $174,000. Quantbot Technologies LP purchased a new stake in Crescent Capital BDC during the second quarter valued at about $219,000. Finally, Adams Asset Advisors LLC purchased a new stake in Crescent Capital BDC during the third quarter valued at about $252,000. Hedge funds and other institutional investors own 49.46% of the company’s stock.
Crescent Capital BDC Price Performance
NASDAQ CCAP opened at $14.27 on Friday. Crescent Capital BDC has a fifty-two week low of $13.31 and a fifty-two week high of $20.19. The business has a fifty day moving average of $14.95 and a 200-day moving average of $14.96. The company has a debt-to-equity ratio of 1.22, a current ratio of 1.27 and a quick ratio of 1.27.
Crescent Capital BDC (NASDAQ:CCAP – Get Free Report) last released its quarterly earnings results on Wednesday, August 13th. The company reported $0.46 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.46. Crescent Capital BDC had a return on equity of 10.55% and a net margin of 24.12%.The company had revenue of $42.99 million during the quarter, compared to analysts’ expectations of $42.52 million. Equities research analysts predict that Crescent Capital BDC will post 2.09 earnings per share for the current year.
Crescent Capital BDC Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Wednesday, October 15th. Investors of record on Tuesday, September 30th were paid a $0.42 dividend. This represents a $1.68 annualized dividend and a yield of 11.8%. The ex-dividend date was Tuesday, September 30th. Crescent Capital BDC’s dividend payout ratio is presently 140.00%.
About Crescent Capital BDC
Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
Read More
- Five stocks we like better than Crescent Capital BDC
- Overbought Stocks Explained: Should You Trade Them?
- Warner Bros. Bidding War Potential: How High Could WBD Shares Go?
- What is the Nasdaq? Complete Overview with History
- Analysts Eye 30% Upside in Netflix After Q3 Earnings Crash
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- O’Reilly Automotive’s Stock Price Uptrend Will Continue in 2026
Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.
